Loading
Latest filing published 23 Nov 2017 for Acasti Pharma Inc., €7,594.
No signal scores available.
Jacqueline Khayat discloses dealings in Acasti Pharma Inc. to SEDI. In total, 2 filings cover trades dated from 1 June 2017 to 20 November 2017.
On the market, this insider has only sold: 1 sale, €7,594 in total.
The newest entry dates from 23 November 2017: an open-market sale of €7,594, in Acasti Pharma Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations